BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32611257)

  • 1. Calcineurin Aβ-Specific Anchoring Confers Isoform-Specific Compartmentation and Function in Pathological Cardiac Myocyte Hypertrophy.
    Li X; Li J; Martinez EC; Froese A; Passariello CL; Henshaw K; Rusconi F; Li Y; Yu Q; Thakur H; Nikolaev VO; Kapiloff MS
    Circulation; 2020 Sep; 142(10):948-962. PubMed ID: 32611257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A perinuclear calcium compartment regulates cardiac myocyte hypertrophy.
    Turcotte MG; Thakur H; Kapiloff MS; Dodge-Kafka KL
    J Mol Cell Cardiol; 2022 Nov; 172():26-40. PubMed ID: 35952391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy.
    Li J; Kritzer MD; Michel JJ; Le A; Thakur H; Gayanilo M; Passariello CL; Negro A; Danial JB; Oskouei B; Sanders M; Hare JM; Hanauer A; Dodge-Kafka K; Kapiloff MS
    Circ Res; 2013 Jan; 112(1):128-39. PubMed ID: 22997248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversibility of adverse, calcineurin-dependent cardiac remodeling.
    Berry JM; Le V; Rotter D; Battiprolu PK; Grinsfelder B; Tannous P; Burchfield JS; Czubryt M; Backs J; Olson EN; Rothermel BA; Hill JA
    Circ Res; 2011 Aug; 109(4):407-17. PubMed ID: 21700928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy.
    Chen X; Nakayama H; Zhang X; Ai X; Harris DM; Tang M; Zhang H; Szeto C; Stockbower K; Berretta RM; Eckhart AD; Koch WJ; Molkentin JD; Houser SR
    J Mol Cell Cardiol; 2011 Mar; 50(3):460-70. PubMed ID: 21111744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
    MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR
    Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin.
    Li J; Negro A; Lopez J; Bauman AL; Henson E; Dodge-Kafka K; Kapiloff MS
    J Mol Cell Cardiol; 2010 Feb; 48(2):387-94. PubMed ID: 19883655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IP3 receptor regulates cardiac hypertrophy in response to select stimuli.
    Nakayama H; Bodi I; Maillet M; DeSantiago J; Domeier TL; Mikoshiba K; Lorenz JN; Blatter LA; Bers DM; Molkentin JD
    Circ Res; 2010 Sep; 107(5):659-66. PubMed ID: 20616315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
    Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
    Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.
    Dong DL; Chen C; Huo R; Wang N; Li Z; Tu YJ; Hu JT; Chu X; Huang W; Yang BF
    Hypertension; 2010 Apr; 55(4):946-52. PubMed ID: 20177001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents.
    Wu X; Chang B; Blair NS; Sargent M; York AJ; Robbins J; Shull GE; Molkentin JD
    J Clin Invest; 2009 Apr; 119(4):976-85. PubMed ID: 19287093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.
    Miller CL; Oikawa M; Cai Y; Wojtovich AP; Nagel DJ; Xu X; Xu H; Florio V; Rybalkin SD; Beavo JA; Chen YF; Li JD; Blaxall BC; Abe J; Yan C
    Circ Res; 2009 Nov; 105(10):956-64. PubMed ID: 19797176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressure overload selectively up-regulates Ca2+/calmodulin-dependent protein kinase II in vivo.
    Colomer JM; Mao L; Rockman HA; Means AR
    Mol Endocrinol; 2003 Feb; 17(2):183-92. PubMed ID: 12554746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoproterenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin.
    Zou Y; Yao A; Zhu W; Kudoh S; Hiroi Y; Shimoyama M; Uozumi H; Kohmoto O; Takahashi T; Shibasaki F; Nagai R; Yazaki Y; Komuro I
    Circulation; 2001 Jul; 104(1):102-8. PubMed ID: 11435346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling.
    Bian ZY; Huang H; Jiang H; Shen DF; Yan L; Zhu LH; Wang L; Cao F; Liu C; Tang QZ; Li H
    Hypertension; 2010 Feb; 55(2):257-63. PubMed ID: 20026769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cardiac myocyte PDE5 levels in human and murine pressure overload hypertrophy contribute to adverse LV remodeling.
    Vandenwijngaert S; Pokreisz P; Hermans H; Gillijns H; Pellens M; Bax NA; Coppiello G; Oosterlinck W; Balogh A; Papp Z; Bouten CV; Bartunek J; D'hooge J; Luttun A; Verbeken E; Herregods MC; Herijgers P; Bloch KD; Janssens S
    PLoS One; 2013; 8(3):e58841. PubMed ID: 23527037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure.
    De Windt LJ; Lim HW; Taigen T; Wencker D; Condorelli G; Dorn GW; Kitsis RN; Molkentin JD
    Circ Res; 2000 Feb; 86(3):255-63. PubMed ID: 10679475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIB1 is a regulator of pathological cardiac hypertrophy.
    Heineke J; Auger-Messier M; Correll RN; Xu J; Benard MJ; Yuan W; Drexler H; Parise LV; Molkentin JD
    Nat Med; 2010 Aug; 16(8):872-9. PubMed ID: 20639889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.